Embed Size (px)
Citation preview
&
Pharmacy
Dispensing Doctors
Prescribing-only GPs (Personal Administration)
Appliance Contractors
2Issue 34
5First page 2 3 4 6
Contents
If you would like to receive Hints & Tips by email, please let us know and we’ll add you to the distribution list. Please email: [email protected] and put ‘Subscribe to Hints & Tips – Dispensing Contractors’ in your subject line. Include the following:
• Name• What type of contractor you are: e.g. pharmacy, appliance, dispensing doctor or GP who
dispenses personally administered items (PADM)• Trading name
Subscribe to Hints & Tips
Issue
35
05
07
08
10
Welcome to Hints and TipsDispensing Contractors
Pharmacy
Dispensing Doctors
Prescribing-only GPs (Personal Administration)
Appliance Contractors
NHS Urgent Medicine Supply Advanced Service (NUMSAS) handy hints
National roll out of Schedule 2 and 3 Controlled Drugs in EPS
3
11 See how using EPS can help save you time
06
05
5
11109 8 7 12
4Issue 34
5First page 2 3 4 6
Welcome to the April 2019 issue of Hints & Tips, your regular newsletter full of helpful ideas and advice.
If you have any suggestions for topics you’d like us to cover in future issues please let us know at [email protected]
Foreword Open days
Our Primary Care Services team offer open days where you can learn more about the reimburse-ment and remuneration process that happens after submitting your prescriptions.
Pharmacy, appliance and dispensing GP contrac-tors will find information from the sessions inval-uable , as well as GPs who claim for personally administered items.
Upcoming dates:
Newcastle (Pharmacy and dispensing GPs) 11 April 1.15pm 2 May 6.00pm 23 May 10.00am 13 June 1.15pm
North West (Pharmacy) 10 April 10.15am 25 April 1.15pm 15 May 10.15am 23 May 1.15pm
(Personally administered GPs) 14 May 10.15am 22 May 5.30pm
Central (Pharmacy and appliance) 10 April 1.30pm 12 June 10.00am
You can sign up here for any of the open days.
Webinars
If you are pushed for time, or have specific queries regarding your account submission, prescription switching, endorsing, or FP10MDA forms, we can offer a webinar service that will run for approximately 30 minutes and can be booked at a time that suits you. If you are interested in any of these topics, email [email protected] to arrange an appointment.
7
11109 8 7 12
6Issue 34
5First page 2 3 4 6
Stickers obscuring prescriber details
We’re seeing an increasing number of prescriptions that have stickers placed over the prescriber details on the bottom of prescription forms.
The name, code and address must be visible in order for our team to process prescriptions correctly. If the whole form is covered, these prescriptions are allocated as national
unidentified. This can lead to inaccuracies in prescribing budgets, prescribing data and ePACT data.
Costs can only be attributed to the CCG if the prescriber details are visible.
The examples below show where stickers should not be placed.
Products now available as licensed medicines
There are some new additions to the dm+d which are licensed and should be considered for use.
Instead of using the following four solutions, a variety of sugar free Actual Medicinal Products (AMPs) are licensed and available and should be considered for use instead. The most recent additions to dm+d are licensed Colonis Pharma Ltd AMPs.
• Levothyroxine sodium 25micrograms/5ml oral solution (special order)
• Levothyroxine sodium 50micrograms/5ml oral solution sugar free (special order)
• Levothyroxine sodium 100micrograms/5ml oral solution sugar free (special order)
• Levothyroxine sodium 125micrograms/5ml oral solution sugar free (special order)
Instead of using Clonidine 50micrograms/5ml oral solution (special order), Thame Laboratories Ltd have recently licensed Clonidine 50micrograms/5ml oral solution sugar free (Thame Laboratories Ltd) x 100ml which should be considered.
Instead of using Amlodipine 5mg/5ml oral suspension (special order), Essential Pharmaceuticals Ltd have recently licensed Amlodipine 5mg/5ml oral suspension sugar free which should be considered. There are already a variety of licensed Amlodipine 5mg/5ml oral solution sugar free AMP options.
MIP Pharma GmbH have recently licensed Cefazolin 2g powder for solution for injection vials (MP Pharma GmbH) which should be considered for use instead of the special order or Imported Cefazolin 2g powder for solution for injection vials AMP options.
Instead of using unlicensed Topiramate 50mg/5ml oral suspension (special order) and unlicensed Topiramate 100mg/5ml oral suspension (special order), the following Rosemont Pharmaceuticals Ltd AMPs are licensed and available:
• Topiramate 50mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd)
• Topiramate 100mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd)
9
11109 8 7 12
8Issue 34
5First page 2 3 4 6
NHS Urgent Medicine Supply Advanced Service (NUMSAS) handy hints
Requests for medicines needed urgently account for about 2% of all completed NHS 111 calls. These calls usually result in a GP appointment to arrange an urgent prescription. This can reduce availability of GP appointments for patients who potentially have a greater clinical need.
NHS England has commissioned a national NHS Urgent Medicine Supply Advanced Service(NUMSAS) pilot via a referral from NHS 111 to help reduce the burden of handling urgent medication requests on urgent and emergency care services. The pilot will ensure that patients still have access to the medicines or appliances they need.
You will start to receive referrals depending on when the service goes live in your area. You will be notified by your local NHS England team when they have decided there are enough pharmacies in your area to provide the service and it can ‘go live’.
You need to ensure that the NHS mail account that you have used to register for the service is a shared email address specific to the premises, and not a personal NHS mail account. If this not the case, please contact your local NHS England pharmacy contracting team.
How to make a claim if you have registered to provide NUMSAS:
• Complete and submit an Urgent Medicine Supply Claim Submission Form for each month in which you have received a referral
• Claim for each month separately
• Complete all sections of the claim form forms will not be accepted without a signature
• Document all referrals on a FP10DT EPS dispensing token
• Remember to document all referrals that do not resultin items being dispensed on a FP10DT EPS dispensing token
• Fully endorse the relevant Standard No Supply Code where appropriate
• Don’t submit any documents other than the FP10DT EPS tokens and your Submission Claims Form. We cannot accept any other documents you send
• Place your completed NUMSAS Submission Claim Form and completed FP10DT EPS dispensing tokens (completed as part of the NUMSAS) in a sealed envelope clearly marked with ‘NUMSAS’ and your pharmacy F Code. Include this envelope with your normal monthly submission bundle
• Ensure that FP10DT EPS tokens completed as part of NUMSAS are separated from other tokens, or there is a risk that the NUMSAS tokens could be scanned and stored with the other tokens and claims will not be reimbursed.
You can find claim forms on the NHSBSA website.
Expand the ‘Submit a claim for payment’ tab, and then download a claim form. These can be copied as necessary after any initial download.If you have any queries relating to payment of claims please contact us on 0300 330 1349. We will contact participating pharmacies where necessary if additional information is needed to ensure the accurate processing of NUMSAS submission claims.
For any queries relating to the service specification, please contact your local NHS England pharmacy contracting team.
11
11109 8 7 12
10Issue 34
5First page 2 3 4 6
The national roll out of controlled drugs (CDs) in EPS for EMIS Web users is now complete. The roll out to SystmOne and Vision completed on 11 March, and all GP practices using these systems are now live with CDs functionality. This means that the number of CD prescriptions you receive via EPS will increase significantly as more GP practices have the functionality switched on.
It is important that all staff working in your pharmacy, including locums, are aware of the roll out and are prepared to dispense an electronic prescription for a controlled drug. If you receive a prescription for a Schedule 2 or 3 CD via EPS, you should dispense it as you would
any other electronic prescription. Processing Schedule 2 & 3 CDs electronically using EPS will make the process safer and more secure.
As patients can nominate any EPS Release 2 enabled pharmacy in England, you could receive an electronic CD prescription at any time, even if there are no GP practices close to where your pharmacy is located with CD functionality. GP practices taking part in the EPS Phase 4 pilot will prescribe CDs electronically for both patients with nominations, and for those without (on Phase 4 tokens).
For more information and best practice guidance, visit the NHS Digital website.
National roll out of Schedule 2 and 3 Controlled Drugs in EPS
See how using EPS can help save you time
Independent community pharmacy contractor and chairman of the Pharmaceutical Services Negotiating Committee’s (PSNC) Resource Development and Finance subcommittee, Mark Burdon, talks about the benefits of maximising EPS.
Five minute read: Implementing EPS, a Pharmacist’s story...
NHS England and Wales Drug Tariff www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance- contractors/drug-tariff
Information about sending in your reimbursement and remuneration claimswww.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance- contractors/submitting-prescriptions/sending-your-claim
NHS Prescription Services open days and webinar sessionswww.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance- contractors/hints-and-tips-open-days-and-webinars
For more information you can access our online knowledge base ‘Ask Us’ at www.nhsbsa.nhs.uk/AskUs or contact us at [email protected]
You can also call us on 0300 330 1349. Our opening hours are 8am to 6pm, Monday to Friday
Useful links on our website
More information
